Aram Andrew Mangasarian

Chief Executive Officer & Non-Executive Director at NOXXON Pharma AG

Aram Andrew Mangasarian

Aram Andrew Mangasarian

Chief Executive Officer & Non-Executive Director at NOXXON Pharma AG

Overview
Career Highlights

NOXXON Pharma NV
NOXXON Pharma AG

RelSci Relationships

79

Number of Boards

3

Birthday

11/1969

Age

51

Contact Data
Trying to get in touch with Aram Andrew Mangasarian? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Aram Andrew Mangasarian likely has professional access to. A relationship does not necessarily indicate a personal connection.

Former Chief Executive Officer at Novexel SA

Relationship likelihood: Strong

Professional at Novo Nordisk A/S

Relationship likelihood: Strong

Managing Partner at TVM Capital GmbH

Relationship likelihood: Strong

Partner, Life Sciences at Andera Partners SCA

Relationship likelihood: Strong

Former Chief Medical Officer at NOXXON Pharma AG

Relationship likelihood: Strong

President at Innovent LLC

Relationship likelihood: Strong

Chief Scientific Officer at NOXXON Pharma AG

Relationship likelihood: Strong

Chief Executive Officer at Deutsche Effecten & Wechsel Beteiligungs AG

Relationship likelihood: Strong

General Partner at Kreos Capital Management (UK) Ltd.

Relationship likelihood: Strong

Chief Executive Officer & Director at Isofol Medical AB

Relationship likelihood: Strong

Paths to Aram Andrew Mangasarian
Potential Connections via
Relationship Science
You
Aram Andrew Mangasarian
Chief Executive Officer & Non-Executive Director at NOXXON Pharma AG
Education

The University of California, San Diego (also referred to as UC San Diego or UCSD) is a public research university located in La Jolla, California, United States. Established in 1960 near the pre-existing Scripps Institution of Oceanography, UCSD is the seventh oldest of the 10 University of California campuses and offers over 200 undergraduate and graduate degree programs. UCSD is one of America's Public Ivy universities, which recognizes top public research universities in the United States.

INSEAD is a graduate business school with campuses in Europe, Asia and the Middle East. INSEAD, widely considered one of the best business schools in the world, allows its students to study in the US (West Coast- San Francisco via Wharton exchange, East Coast- Philadelphia via Wharton exchange, Midwest- Evanston near Chicago via Kellogg exchange), in Asia (Singapore via INSEAD Asia Campus exchange and Shanghai via CEIBS exchange), in the Middle East (Abu Dhabi via INSEAD Middle East Campus exchange) and in Europe (Fontainebleau via INSEAD Europe Campus exchange)

BS Biochemistry

The University of Wisconsin–Madison has long been recognized as one of America's great universities. A public, land-grant institution, UW–Madison offers a complete spectrum of liberal arts studies, professional programs and student activities. Spanning 936 acres along the southern shore of Lake Mendota, the campus is located in the city of Madison.

Career History
Chief Executive Officer
2015 - Current

NOXXON Pharma NV is a clinical-stage biopharmaceutical company, which focuses on cancer treatment. Its oncology-focused pipeline acts on the cancer immunity cycle, which exposes hidden tumor cells by breaking the tumor protection barrier, blocking tumor repair. The company was founded on January 16, 2015 and is headquartered in Amsterdam, the Netherlands.

Chief Executive Officer & Non-Executive Director
2010 - Current

NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.

Vice President-Business Development
2005 - Prior

Novexel SA researches and develops anti-infective drugs for the treatment of bacterial and fungal infections. The firm focuses on discovery and development of novel antibiotics designed to overcome the significant global problem of microbial resistance. The company was founded in December 2004 and is headquartered in Romainville, France.

Boards & Committees
Chief Executive Officer & Non-Executive Director
2010 - Current

NOXXON Pharma AG operates a clinical stage biotechnology company. Its core focus is on cancer treatment. The firm offers effectiveness of cancer treatments including immuno-oncology approaches such as immune checkpoint inhibition and current standards of care such as chemotherapy and radiotherapy. The company was founded in 1997 by Sven Klussmann, Jens-Peter Fürste and Thomas Klein and is headquartered in Berlin, Germany.

Director
Prior

Caerus Consulting AS engages in the research and development in biotechnology. It develops antibiotics for life threatening bacterial diseases. Its technological core is chemistry on complex molecules. The company was founded by Torgeir Vaage on March 31, 2009 and is headquartered in Hovik, Norway.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$500 - $999
2015

A SUPPORTING ORGANIZATION OF THE WISCONSIN YOUTH SYMPHONY ORCHESTRA, INC.

$500 - $999
2014

A SUPPORTING ORGANIZATION OF THE WISCONSIN YOUTH SYMPHONY ORCHESTRA, INC.

$500 - $999
2013

A SUPPORTING ORGANIZATION OF THE WISCONSIN YOUTH SYMPHONY ORCHESTRA, INC.

Investments
Details Hidden

NOXXON Pharma NV is a clinical-stage biopharmaceutical company, which focuses on cancer treatment. Its oncology-focused pipeline acts on the cancer immunity cycle, which exposes hidden tumor cells by breaking the tumor protection barrier, blocking tumor repair. The company was founded on January 16, 2015 and is headquartered in Amsterdam, the Netherlands.

Other Affiliations
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Aram Andrew Mangasarian. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Aram Andrew Mangasarian's profile does not indicate a business or promotional relationship of any kind between RelSci and Aram Andrew Mangasarian.